Literature DB >> 6365979

Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia.

I F Rowe, A M Worsley, P Donnelly, D Catovsky, J M Goldman, D Galton, M B Pepys.   

Abstract

C reactive protein concentration was measured serially in 19 patients with leukaemia after bone marrow transplantation. Six episodes of graft versus host disease occurred in the presence of fever but with no evidence of infection, and these were associated with C reactive protein concentrations as high as 200 mg/l. C reactive protein values were also increased in 12 febrile episodes associated with infection, in seven of which graft versus host disease was also present. C reactive protein concentrations are of no value in differentiating infection from graft versus host disease, but in both cases they may be useful as an objective index of response to appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365979      PMCID: PMC498696          DOI: 10.1136/jcp.37.3.263

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

Review 1.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

2.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

3.  The detection of infection in leukaemia by serial measurement of C-reactive protein.

Authors:  M Williams; J McCallum; H M Dick
Journal:  J Infect       Date:  1982-03       Impact factor: 6.072

4.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

5.  Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.

Authors:  M B Pepys; A C Dash; R E Markham; H C Thomas; B D Williams; A Petrie
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

6.  C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia.

Authors:  K P Schofield; F Voulgari; D I Gozzard; M J Leyland; N J Beeching; J Stuart
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

7.  Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.

Authors:  R L Powles; H M Clink; D Spence; G Morgenstern; J G Watson; P J Selby; M Woods; A Barrett; B Jameson; J Sloane; S D Lawler; H E Kay; D Lawson; T J McElwain; P Alexander
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

  7 in total
  6 in total

1.  Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.

Authors:  M Uguccioni; R Meliconi; E Lalli; S Nesci; C Delfini; G Lucarelli; G Gasbarrini; A Facchini
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation.

Authors:  R E Chambers; C W Hutton; P A Dieppe; J T Whicher
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

3.  C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation.

Authors:  C de Bel; E Gerritsen; G de Maaker; A Moolenaar; J Vossen
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

4.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

Authors:  S A Walker; T R Rogers; P G Riches; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

5.  Antithrombin III in the diagnosis of infection in febrile neutropenic patients.

Authors:  C C Kibbler; H G Prentice; P Noone
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

6.  Peri-operative elastase-alpha-1 proteinase inhibitor in patients with postoperative intervertebral discitis.

Authors:  A Huber; C Kainz; A Witzmann; H Beran; J Fischer
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.